Logo image of PRSO

PERASO INC (PRSO) Stock Fundamental Analysis

NASDAQ:PRSO - Nasdaq - US71360T2006 - Common Stock - Currency: USD

0.917  +0.02 (+1.89%)

After market: 0.917 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PRSO. PRSO was compared to 109 industry peers in the Semiconductors & Semiconductor Equipment industry. PRSO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PRSO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year PRSO has reported negative net income.
In the past year PRSO has reported a negative cash flow from operations.
PRSO had negative earnings in each of the past 5 years.
PRSO had a negative operating cash flow in each of the past 5 years.
PRSO Yearly Net Income VS EBIT VS OCF VS FCFPRSO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M

1.2 Ratios

PRSO has a Return On Assets of -251.65%. This is amonst the worse of the industry: PRSO underperforms 99.08% of its industry peers.
With a Return On Equity value of -893.68%, PRSO is not doing good in the industry: 96.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -251.65%
ROE -893.68%
ROIC N/A
ROA(3y)-107.86%
ROA(5y)-80.26%
ROE(3y)-216.54%
ROE(5y)-169.05%
ROIC(3y)N/A
ROIC(5y)N/A
PRSO Yearly ROA, ROE, ROICPRSO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

PRSO has a worse Gross Margin (21.73%) than 77.98% of its industry peers.
In the last couple of years the Gross Margin of PRSO has declined.
The Profit Margin and Operating Margin are not available for PRSO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.83%
GM growth 5Y-26.1%
PRSO Yearly Profit, Operating, Gross MarginsPRSO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

4

2. Health

2.1 Basic Checks

PRSO does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for PRSO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRSO Yearly Shares OutstandingPRSO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K
PRSO Yearly Total Debt VS Total AssetsPRSO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -39.62, we must say that PRSO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -39.62, PRSO is doing worse than 88.07% of the companies in the same industry.
PRSO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -39.62
ROIC/WACCN/A
WACC10.98%
PRSO Yearly LT Debt VS Equity VS FCFPRSO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

PRSO has a Current Ratio of 1.08. This is a normal value and indicates that PRSO is financially healthy and should not expect problems in meeting its short term obligations.
PRSO has a worse Current ratio (1.08) than 88.07% of its industry peers.
PRSO has a Quick Ratio of 1.08. This is a bad value and indicates that PRSO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.56, PRSO is not doing good in the industry: 91.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.56
PRSO Yearly Current Assets VS Current LiabilitesPRSO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.23% over the past year.
EPS 1Y (TTM)88.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%100.76%

3.2 Future

PRSO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.42% yearly.
Based on estimates for the next years, PRSO will show a small growth in Revenue. The Revenue will grow by 7.63% on average per year.
EPS Next Y44.56%
EPS Next 2Y35.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.34%
Revenue Next 2Y17.28%
Revenue Next 3Y7.63%
Revenue Next 5YN/A

3.3 Evolution

PRSO Yearly Revenue VS EstimatesPRSO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
PRSO Yearly EPS VS EstimatesPRSO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 0 -1K -2K -3K -4K

1

4. Valuation

4.1 Price/Earnings Ratio

PRSO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PRSO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRSO Price Earnings VS Forward Price EarningsPRSO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRSO Per share dataPRSO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as PRSO's earnings are expected to grow with 35.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.42%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PRSO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PERASO INC

NASDAQ:PRSO (4/25/2025, 4:39:54 PM)

After market: 0.917 0 (0%)

0.917

+0.02 (+1.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-19 2025-03-19/amc
Earnings (Next)05-12 2025-05-12/amc
Inst Owners12.77%
Inst Owner Change0%
Ins Owners3.29%
Ins Owner Change0.84%
Market Cap4.44M
Analysts85
Price Target3.35 (265.32%)
Short Float %1.58%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-89.11%
Min EPS beat(2)-136.37%
Max EPS beat(2)-41.84%
EPS beat(4)1
Avg EPS beat(4)-65.44%
Min EPS beat(4)-136.37%
Max EPS beat(4)38.59%
EPS beat(8)4
Avg EPS beat(8)-23.5%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.47%
Min Revenue beat(2)-6.79%
Max Revenue beat(2)-2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.79%
Min Revenue beat(4)-6.79%
Max Revenue beat(4)5.65%
Revenue beat(8)4
Avg Revenue beat(8)0.22%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.93%
PT rev (3m)-4.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.59%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 2.19
P/tB 3.71
EV/EBITDA N/A
EPS(TTM)-2.18
EYN/A
EPS(NY)-1.21
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS2.63
BVpS0.42
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -251.65%
ROE -893.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.73%
FCFM N/A
ROA(3y)-107.86%
ROA(5y)-80.26%
ROE(3y)-216.54%
ROE(5y)-169.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.83%
GM growth 5Y-26.1%
F-Score3
Asset Turnover1.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.02%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.56
Altman-Z -39.62
F-Score3
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)18.87%
Cap/Depr(5y)32.39%
Cap/Sales(3y)3.88%
Cap/Sales(5y)2.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.47%
EPS Next Y44.56%
EPS Next 2Y35.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%100.76%
Revenue Next Year0.34%
Revenue Next 2Y17.28%
Revenue Next 3Y7.63%
Revenue Next 5YN/A
EBIT growth 1Y2.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.37%
EBIT Next 3Y23%
EBIT Next 5YN/A
FCF growth 1Y84.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.92%
OCF growth 3YN/A
OCF growth 5YN/A